Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment

RATIONALE: Relapsed or refractory peripheral T-cell lymphomas are aggressive diseases. Pralatrexate is an antimetabolite. Hereby, we are reporting a pralatrexate induced durable response in a relapsed/refractory peripheral T-Cell lymphoma patient with a history of autologous stem cell transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Merdin, Alparslan, İskender, Dicle, Ulu, Bahar Uncu, Doğan, Mehmet, Çakar, Merih Kizil, Dal, Mehmet Sinan, Altuntaş, Fevzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709046/
https://www.ncbi.nlm.nih.gov/pubmed/31348254
http://dx.doi.org/10.1097/MD.0000000000016482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709046/
https://www.ncbi.nlm.nih.gov/pubmed/31348254
http://dx.doi.org/10.1097/MD.0000000000016482

Ejemplares similares